Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Galderma Group AG - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GALDY
Over the counter
2830
www.galderma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Galderma Group AG
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
- Jul 6th, 2026 11:00 pm
Galderma falls after FDA issues second setback for Botox rival
- Jul 1st, 2026 2:08 am
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States
- Jun 30th, 2026 11:00 pm
Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year?
- Jun 16th, 2026 7:40 am
Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments
- Jun 10th, 2026 11:00 pm
What Makes Galderma Group AG - Unsponsored ADR (GALDY) a New Strong Buy Stock
- May 5th, 2026 10:00 am
European Market Insights 3 Stocks Estimated Below Fair Value
- Apr 29th, 2026 4:37 am
3 European Stocks Estimated To Be Up To 48.1% Below Intrinsic Value
- Apr 28th, 2026 11:38 pm
Assessing Galderma Group (SWX:GALD) Valuation After Recent Share Price Resilience
- Mar 26th, 2026 12:07 pm
EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever
- Mar 13th, 2026 12:17 pm
Assessing Galderma Group (SWX:GALD) Valuation After Record 2025 Results And Upgraded Nemluvio Outlook
- Mar 8th, 2026 1:06 pm
Galderma Group AG (GDERF) Full Year 2025 Earnings Call Highlights: Record Sales and Strategic ...
- Mar 5th, 2026 12:00 pm
European Stocks That May Be Trading Below Their Estimated Value In February 2026
- Feb 17th, 2026 3:38 am
Global Market Highlights 3 Stocks That May Be Trading Below Their Estimated Value
- Feb 17th, 2026 2:38 am
European Market Highlights 3 Stocks Priced Below Estimated Value
- Feb 16th, 2026 10:38 pm
3 European Stocks Estimated To Be Trading Up To 48.2% Below Intrinsic Value
- Feb 16th, 2026 3:37 am
3 European Stocks Estimated To Be Trading Up To 39.9% Below Intrinsic Value
- Feb 15th, 2026 10:38 pm
3 European Stocks Possibly Trading At Discounts Of Up To 39.3%
- Feb 13th, 2026 3:38 am
3 European Stocks Estimated To Be Up To 49.8% Below Intrinsic Value
- Feb 12th, 2026 10:38 pm
Galderma Group (SWX:GALD) Valuation Check After Recent Share Price Weakness And R&D Driven Growth Hopes
- Jan 30th, 2026 7:12 pm
Scroll